The impact of increased mirabegron usage and decreased switching on healthcare costs and resource utilization in patients with overactive bladder in the United States: A retrospective database analysis

Research Type

Clinical

Abstract Category

Overactive Bladder

Links
	Abstract 880
	Non Discussion Abstracts Scientific Non Discussion Abstract Session 41
	Overactive Bladder Outcomes Research Methods Retrospective Study
	1. Astellas Pharma Global Development, 2. Medicus Economics LLC
Abstract PDF Edit Abstract Abstract Centre